Age-related Macular Degeneration
Showing NaN - NaN of 18
Age-Related Macular Degeneration, Diabetic Retinopathy, Central Serous Chorioretinopathy Trial in New York (OCT Imaging Using
Not yet recruiting
- Age-Related Macular Degeneration
- +5 more
- OCT Imaging Using Device N
- OCT Imaging Using Device C
-
New York, New YorkNYU Langone Health
Jan 6, 2023
Visual Impairment, Age-Related Macular Degeneration, Diabetic Retinopathy Trial in New York (In-House Developed VR Platform -
Recruiting
- Visual Impairment
- +3 more
- In-House Developed VR Platform - AMD, DR, Glaucoma
- In-House Developed VR Platform - Glaucoma
-
New York, New YorkNYU Langone Health
Oct 6, 2022
Choroidal Ischemia, Vitelliform Macular Dystrophy, Age-related Macular Degeneration Trial in New York (drug, other, diagnostic
Recruiting
- Choroidal Ischemia
- +4 more
- Sildenafil
- +3 more
-
New York, New YorkColumbia University Medical Center, Edward Harkness Eye Institut
May 2, 2022
Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States
Completed
- Age-related Macular Degeneration
- +2 more
- bevacizumab
- ranibizumab
-
Tucson, Arizona
- +49 more
Feb 15, 2022
Age-Related Macular Degeneration Trial in Worldwide (E10030, bevacizumab or aflibercept, E10030 sham injection)
Age-related Macular Degeneration, Coronary Artery Disease, Cardiovascular Diseases Trial in New York (Blood draw)
Unknown status
- Age-related Macular Degeneration
- +2 more
- Blood draw
-
New York, New YorkNew York Eye and Ear Infirmary
Sep 10, 2019
Age-Related Macular Degeneration Trial in Worldwide (E10030, ranibizumab, E10030 sham intravitreal injection)
Age-related Macular Degeneration Trial in United States (Squalamine lactate ophthalmic solution, 0.2%, Placebo Ophthalmic
Unknown status
- Age-related Macular Degeneration
- Squalamine lactate ophthalmic solution, 0.2%
- +2 more
-
Mobile, Alabama
- +117 more
Apr 25, 2017
Age-Related Macular Degeneration Trial in United States (Squalamine Lactate Ophthalmic Solution, 0.2%, Placebo Ophthalmic
Withdrawn
- Age-Related Macular Degeneration
- Squalamine Lactate Ophthalmic Solution, 0.2%
- +2 more
-
Beverly Hills, California
- +3 more
Apr 25, 2017
Age-Related Macular Degeneration Trial in United States (HuCNS-SC sub-retinal transplantation)
Terminated
- Age-Related Macular Degeneration
- HuCNS-SC sub-retinal transplantation
-
Tucson, Arizona
- +11 more
May 31, 2016
Age-related Macular Degeneration Trial in United States (Ranibizumab)
Completed
- Age-related Macular Degeneration
-
Phoenix, Arizona
- +98 more
Dec 11, 2012
Age-Related Macular Degeneration Trial in Israel, United States (PF-04523655)
Completed
- Age-Related Macular Degeneration
-
Beverly Hills, California
- +10 more
Oct 5, 2012
Ultrasonic Evaluation of Ocular Tissues
Unknown status
- Glaucoma
- +2 more
- high frequency ultrasound examination
-
New York, New YorkWeill Cornell Medical College
Jan 19, 2010
Age-Related Macular Degeneration Trial in United States (OT-551, vehicle )
Unknown status
- Age-Related Macular Degeneration
- OT-551
- vehicle placebo
-
Mesa, Arizona
- +17 more
Mar 31, 2008